Enterovirus, vaccines, medicaments and diagnostic kits

An isolated and/or recombinant nucleic acid that is at least 95% homologous to a nucleic acid sequence selected from the group consisting of SEQ ID NO:

• 82 and SEQ ID NO:
• 61.

An isolated and/or recombinant nucleic acid comprising a stretch of 100 consecutive nucleotides of a nucleic acid sequence selected from the group consisting of SEQ ID NO:

• 82 and SEQ ID NO:
• 61.

An isolated and/or recombinant nucleic acid encoding a proteinaceous molecule comprising an amino acid sequence selected from the group consisting of SEQ ID NO:83, SEQ ID NO:39, SEQ ID NO:40, SEQ ID NO:41, SEQ ID NO:42, SEQ ID NO:50, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53, SEQ ID NO:54, SEQ ID NO:55, SEQ ID NO:56, and SEQ ID NO:63.

A primer and/or probe comprising a nucleic acid sequence selected from the group consisting of SEQ ID NO:35, SEQ ID NO:36, SEQ ID NO:37, and SEQ ID NO:38.

A polycistronic messenger RNA comprising an internal ribosomal entry site (IRES) that comprises positions 1 to 748 of SEQ ID NO:82.

A chimeric enterovirus comprising at least 1000 consecutive nucleotides of SEQ ID NO:

• 82 and at least 1000 consecutive nucleotides of another enterovirus wherein said latter 1000 consecutive nucleotides comprise a sequence that is more than 5% sequence divergent with SEQ ID NO:
• 82.